TrialThe Journal of infectious diseases2018

Hepatic Pharmacokinetics and Pharmacodynamics With Ombitasvir/Paritaprevir/Ritonavir Plus Dasabuvir Treatment and Variable Ribavirin Dosage.

Andrew H Talal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.